Live feed16:14:19·987dSECFilingSorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and ExhibitsSRNE· Sorrento Therapeutics Inc.Health CareOriginal source